Oxford BioMedica
Discover Realise

Senior Management Team

John Dawson

Chief Executive Officer

John Dawson joined Oxford BioMedica’s Board as non-Executive Director on 1 August 2008. He was appointed Chief Executive Officer on 13 October 2008, having served as Acting Chief Executive Officer since 29 August 2008. From 1996 to 2007 he held senior management positions in the European operations of Cephalon Inc., including from 2005, a management board position as Chief Financial Officer and Head of Business Development Europe. In his time at Cephalon he led the many deals that built the European business to over 1,000 people, taking the business from having no sales in 1998 to a turnover of several hundred million US dollars. In 2005 he led the US$360 million acquisition of Zeneus by Cephalon. Between 1991 and 1996 he was Director of Finance and Administration of Serono Laboratories (UK) Limited. Mr Dawson is currently a non-executive director of Paion AG.

John Dawson

Team expertise:

  • Leadership and strategy
  • Business development

Tim Watts

Chief Financial Officer

Tim Watts joined Oxford BioMedica and the Board in February 2012. He has over 30 years' experience in leading multinational and entrepreneurial businesses, 20 of which in the pharmaceutical and biotech sectors. Tim qualified as a chartered accountant, beginning his career with Coopers & Lybrand before moving to H J Heinz, the food producer. In 1985 he joined ICI, initially in the corporate headquarters and from 1990 in the pharmaceuticals division, eventually rising to be Finance Director of the Zeneca Pharmaceuticals business. Following the merger of Astra and Zeneca, Tim became Group Financial Controller of AstraZeneca PLC in 2001. In 2007 he left AstraZeneca to become Chief Financial Officer of Archimedes Pharma. He has a proven track record in the industry, including managing corporate transactions, M&A activity, fundraising and strategic implementation.  Mr Watts is a member of the Institute of Chartered Accountants in England and Wales.

Tim Watts

Team expertise:

  • Financial management
  • Strategic implementation

Peter Nolan

Chief Business Officer

Peter Nolan was appointed to Oxford BioMedica's Board in May 2002, having been a senior member of the Company since its foundation. Until the end of 2013, he was also a Director of the UK BioIndustry Association and is a past chairman of the Oxfordshire Bioscience Network. He has broad experience and knowledge of the biotechnology sector. Prior to joining Oxford BioMedica, he served as head of the Biotechnology Unit at the UK Department of Trade & Industry for eight years. In that role he was responsible for establishing and managing complex collaborative research programmes involving industry, research councils and other government departments. Previously he held senior positions in the Laboratory of the Government Chemist and also the Metropolitan Police Laboratory in London where he was a senior forensic scientist.

Peter Nolan

Team expertise:

  • In/out-licensing, collaborations and legal issues
  • Intellectual property strategy and management

Kyriacos Mitrophanous

Chief Scientific Officer

Over 18 years of experience in the development  of clinically relevant lentiviral vector based medicines, platform technology, production and analytics. Kyriacos has overall responsible for the new product development activities as well as analytical and LentiVector® platform. Kyriacos is also responsible for co-leadership of all the technical aspects of the alliance management of the collaborative programmes. Kyriacos is a named inventor on several patents in the field.

Kyriacos Mitrophanous

Team expertise:

  • Process development
  • Regulatory
  • Alliance technical management
  • Analytics

James Miskin

Chief Technical Officer

James has over 14 years of experience in GxP assay development, routine testing, lentiviral based vector manufacturing development and cGMP manufacturing. In his current role he has overall responsibility for  all manufacturing and supply activities, as well as manufacturing development. James is also responsible for co-leadership of all the technical aspects of the alliance management of the collaborative programmes. James is a named inventor on several patents in the field.

James Miskin

Team expertise:

  • Manufacturing
  • Process development
  • Regulatory
  • Alliance technical management